Ikena Oncology Inc Stock, NASDAQ:IKNA
645 Summer Street, Suite 101, Boston, Massachusetts 02210
United States of America
Number of Employees: 67
Ikena Oncology, Inc. is a clinical stage biotechnology company. It discovers and develops patient directed, biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412 and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.